CRVL Form 4: Brandon O'Brien Disposes 1,764 Shares at $91.54

Rhea-AI Filing Summary

Brandon O'Brien, identified as Chief Financial Officer of CorVel Corp (CRVL), reported a sale of company stock on 09/08/2025. The Form 4 shows 1,764 shares were sold at a price of $91.5367 per share, leaving 8,948 shares beneficially owned following the transaction. The filing was submitted on behalf of Mr. O'Brien by Sharon O'Connor on 09/10/2025. The disposition is reported as a direct holding.

Positive

• Transaction is properly disclosed under Section 16, showing regulatory compliance
• Reporting shows remaining direct ownership of 8,948 shares, indicating continued insider stake

Negative

• CFO sold 1,764 shares at $91.5367 on 09/08/2025
• Filing provides no explanation for the sale; motives are not disclosed in the Form 4

Insights

Securities Analyst

TL;DR: Routine officer sale of shares; transaction is factual disclosure without additional company context.

The Form 4 records a direct sale of 1,764 CorVel shares by CFO Brandon O'Brien at $91.5367 per share, leaving 8,948 shares owned. The report is a standard Section 16 disclosure showing an insider disposition; the filing contains no indication of a planned trading arrangement or derivative activity. This disclosure alone does not provide information on the companys operational performance or motives behind the sale.

Corporate Governance Expert

TL;DR: Insider compliance filing completed; sale appears routine and properly reported.

The Form 4 identifies the reporting person as an officer (Chief Financial Officer) and records a direct sale. The document includes signature by an agent and the transaction date and price. There are no accompanying amendments, derivatives, or indications of additional related-party arrangements disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Brien Brandon

(Last) (First) (Middle)

5128 APACHE PLUME ROAD, SUITE 400

(Street)

FORT WORTH TX 75109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CORVEL CORP [ CRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2025		S		1,764	D	$91.5367	8,948	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: Sharon O'Connor For: Brandon O'Brien	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CorVel (CRVL) insider Brandon O'Brien report on Form 4?

The Form 4 reports that Brandon O'Brien sold 1,764 shares of CorVel common stock on 09/08/2025 at $91.5367 per share, leaving 8,948 shares owned.

What is Brandon O'Briens role at CorVel listed on the Form 4?

He is listed as an officer with the title Chief Financial Officer.

Was the sale reported as direct or indirect ownership?

The Form 4 lists the ownership form as Direct (D) for the reported shares.

When was the Form 4 signed and who signed it?

The filing was signed on behalf of Brandon O'Brien by Sharon O'Connor with the signature date shown as 09/10/2025.

Does this Form 4 show any derivative transactions or 10b5-1 plan notation?

No. The filing lists a non-derivative sale and contains no mention of derivative securities or a 10b5-1 trading plan.